FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Fatty Acid topics
Fatty Acid
Fatty Acids
Hydrocarbon
Carbon Dioxide
Internal Combustion Engine
Alkali Metal
Unsaturated Fat
Saturated Fat
Fatty Acid Amide
Carbon Atoms
Crystallize
Crystallin
Chemical Reaction
Carboxylic Acid
Electrolytic Cell

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Fatty Acid patents



      
           
This page is updated frequently with new Fatty Acid-related patents. Subscribe to the Fatty Acid RSS feed to automatically get the update: related Fatty RSS feeds.

Subscribe to updates on this page: Fatty Acid RSS RSS

Date/App# patent app List of recent Fatty Acid-related patents
04/17/14
20140107361
 Modifying the fatty acid profile of camelina sativa oil patent thumbnailnew patent Modifying the fatty acid profile of camelina sativa oil
The present disclosure provides methods and compositions for modifying fatty acids in camelina sativa oil. Fatty acid desaturase 2 (fad2), fatty acid desaturase 3 (fad3), and/or fatty acid elongase 1 (fae1) genes regulate fatty acid composition in camelina oil..
04/17/14
20140107359
 Heated chromatographic separation process patent thumbnailnew patent Heated chromatographic separation process
The present invention provides a chromatographic separation process for recovering a polyunsaturated fatty acid (pufa) product from a feed mixture, which process comprises passing the feed mixture through one or more chromatographic columns containing, as eluent, an aqueous organic solvent, wherein the temperature of at least one of the chromatographic columns through which the feed mixture is passed is greater than room temperature.. .
04/17/14
20140107229
 Oil-in-water emulsions patent thumbnailnew patent Oil-in-water emulsions
The invention relates to oil-in-water emulsions based on fatty alcohols and mono- or diesters of glycerol and the use thereof as antifoams or deaerators for aqueous compositions. The oil phase of the emulsions according to the invention consists to at least 95% by weight of the following constituents: a) 40 to 95% by weight, based on the total weight of the oil phase, of a mixture of at least two alcohols as component a, consisting of: a1) at least one alkanol having 12 to 30 carbon atoms as component a1, a2) at least one mono- or diester of glycerol with at least one fatty acid having 14 to 24 carbon atoms as component a2; b) 0.1 to 10% by weight, based on the total weight of the oil phase, of at least one further component b, which is selected from esters of c12-c36-alkanecarboxylic acids with polyglycerol, amides of c12-c36-alkanecarboxylic acids with alkylenediamines or oligoalkyleneamines, and esters of c12-c36-alkanecarboxylic acids with c12-c36-alkanols, and mixtures thereof, c) 4.9 to 50% by weight, based on the total weight of the oil phase, of at least one further component c, which is selected from organic substances which are liquid at 50° c.
04/17/14
20140107206
 Omega-3 pentaenoic acid compositions and methods of use patent thumbnailnew patent Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids comprising omega-3-fatty acids, salts or derivatives thereof are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/17/14
20140107205
 Omega-3 pentaenoic acid compositions and methods of use patent thumbnailnew patent Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids, wherein at least 50% by weight of the fatty acids comprise omega-3-fatty acids, salts or derivatives thereof, wherein the omega-3 fatty acids comprise eicosapentaenoic acid (epa; c20:5-n3), docosapentaenoic acid (dpa; c22:5-n3), and docosahexaenoic acid (dha; c22:6-n3), wherein the ratio of dha to epa (dha:epa) is less than 1:20, and wherein the ratio of dha to dpa (dha:dpa) is less than 2:1 are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/17/14
20140107200
 Omega-3 pentaenoic acid compositions and methods of use patent thumbnailnew patent Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids comprising omega-3-fatty adds, salts or derivatives thereof are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/17/14
20140107199
 Omega-3 pentaenoic acid compositions and methods of use patent thumbnailnew patent Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids comprising omega-3-fatty acids, salts or derivatives thereof are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/17/14
20140107198
 Omega-3 pentaenoic acid compositions and methods of use patent thumbnailnew patent Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids, wherein at least 50% by weight of the fatty acids comprise omega-3-fatty acids, salts or derivatives thereof, wherein the omega-3 fatty acids comprise eicosapentaenoic acid (epa; c20:5-n3), docosapentaenoic acid (dpa; c22:5-n3), and docosahexaenoic acid (dha; c22:6-n3), wherein the ratio of dha to epa (dha:epa) is less than 1:20, and wherein the ratio of dha to dpa (dha:dpa) is less than 2:1 are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/17/14
20140107081
 Salicylic acid topical formulation patent thumbnailnew patent Salicylic acid topical formulation
Topical skin treatment formulation containing salicylic acid or a derivative thereof, dissolved in a solvent system comprising (i) dimethyl isosorbide; (ii) a c1 to c9 alkyl salicylate; and (iii) a glyceryl fatty acid ester. The solvent system may also comprise an alcohol, a polyoxyalkylene-based solvent, and/or a c1 to c4 alkyl glucose ester.
04/17/14
20140107063
 Osteoarthritis diet formulations patent thumbnailnew patent Osteoarthritis diet formulations
Dietary formulations and methods for treating, preventing or delay onset of osteoarthritis in canines and other animals are disclosed. The formulations are enriched in n-3 fatty acids and limited in n-6 fatty acids..
04/17/14
20140106993
new patent Systems and methods for processing glycerol
Systems and methods for processing glycerol into one or more products and uses thereof are provided. In one or more embodiments, a method for treating soil can include applying a partially oxidized reaction product to a soil.
04/17/14
20140106047
new patent Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
A composition and method for supplementing food, nutrition, and diet systems with omega-6 to omega-3 balanced oils comprising a synergistic blend of at least two oils. The composition further comprises a synergistic blend of long chain omega-3 oil as a means to further increase the nutritional value.
04/17/14
20140106035
new patent Health-giving foodstuff containing ethyl esters of fatty acids, namely of linen oil, and method for obtaining the same
The subject of invention is the health-giving foodstuff containing ethyl esters of fatty acids of linen oil or linen oil and fish oil, characterised in that it constitutes of microcapsules in form of powder, which contains, in a protein-carbohydrate matrix, a nutraceutical with bioactive ethyl esters of acids ala, la or ala, la, dha, epa with not more than 4 percent by weight addition of ethanol, based on at least 99.8% anhydrous pharmaceutical ethanol, in form of drops of diameter less than 21.1m. The nature of the invention is also a method for obtaining of the health-giving foodstuff containing ethyl esters of fatty acids, namely of linen oil or linen oil and fish oil, by mixing of ingredients, their homogenisation, drying, characterised by that after obtaining liquid protein-carbohydrate matrix, a nutraceutical containing bioactive ethyl esters of acids ala, la or ala, la, dha, epa is introduced into it, followed by carrying out of dispergation of ester phase by mechanical agitation until stable form of emulsion is obtained, which is then treated with two-steps and two-stages pressure homogenisation: in 1st stage—at pressure of at least 20 mpa on the 1st step and 4 mpa at the 2nd step, and in 2nd stage—at pressure of at least 30 mpa on the 1st step and 10 mpa at the 2nd step, whilst homogenisation during the 1st stage is carried out in process coupled with thermal processing of the emulsion, which is then spray dried in atmosphere of temperature 160-190° c.
04/17/14
20140106028
new patent Methods and kits for co-administration of nutritional supplements
The present invention relates to methods of co-administration of various vitamin and mineral compositions, and in a specific embodiment, said methods comprise co-administering one composition comprising vitamin a, vitamin d, vitamin c, vitamin e, folic acid, vitamin b1, vitamin b2, vitamin b6, vitamin b12, niacin, calcium, iron, magnesium, zinc, and/or copper, and a second composition comprising omega-3 fatty acids such as dha, to supplement the nutritional needs of individuals within physiologically stressful states; and kits provided for co-administration of various vitamin and mineral compositions, and in a specific embodiment, said kits comprise one composition comprising vitamin a, vitamin d, vitamin c, vitamin e, folic acid, vitamin b1, vitamin b2, vitamin b6, vitamin b12, niacin, calcium, iron, magnesium, zinc, and/or copper, and a second composition comprising omega-3 fatty acids such as dha, to supplement the nutritional needs of individuals within physiologically stressful states.. .
04/17/14
20140106027
new patent Kits and methods for nutrition supplementation
The present invention relates to methods of co-administration of various vitamin and mineral compositions, and in a specific embodiment, said methods comprise co-administering one composition comprising vitamin a, beta carotene, b-complex vitamins, vitamin c, vitamin d3, vitamin e, iron, magnesium and zinc, and a second composition comprising omega-3 fatty acids such as dha, to supplement the nutritional needs of individuals within physiologically stressful states; and kits provided for co-administration of various vitamin and mineral compositions, and in a specific embodiment, said kits comprise one composition comprising vitamin a, beta carotene, b-complex vitamins, vitamin c, vitamin d3, vitamin e, iron, magnesium and zinc, and a second composition comprising omega-3 fatty acids such as dha, to supplement the nutritional needs of individuals within physiologically stressful states.. .
04/17/14
20140105875
new patent Nutritional compositions having exogenous milk fat globule membrane components
Nutritional compositions including milk fat globule membrane components (“mfgm”) and at least one nutrient are provided. The milk-derived, bioactive lipids help to modulate conditions typically found in the elderly including, for example, low-grade inflammation, loss of lean body mass, skeletal muscle cell membrane instability, and joint inflammation.
04/17/14
20140104353
new patent Phase change inks comprising fatty acids
A solid ink composition suitable for ink jet printing, including printing on coated paper substrates. In embodiments, the solid ink composition comprises both a crystalline compound and an amorphous compound, and a fatty acid, which provides for a robust ink wherein the phase change ink crystallizes faster from the liquid state than the same composition without the fatty acid..
04/17/14
20140102654
new patent Method and system using low fatty acid starches in paper sizing composition to inhibit deposition of multivalent fatty acid salts
A method for inhibiting deposition of multivalent saturated fatty acids on paper sizing equipment and/or devices which use a paper surface sizing composition containing higher starch solids levels of surface sizing starches and a source of multivalent cations, such as a multivalent metal drying salt, by including (wholly or partially) one or more low fatty acid surface sizing starches in the paper surface sizing composition. Also, a paper surface sizing system for carrying out this method..
04/10/14
20140100281
Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids, wherein at least 50% by weight of the fatty acids comprise omega-3-fatty acids, salts or derivatives thereof, wherein the omega-3 fatty acids comprise eicosapentaenoic acid (epa; c20:5-n3), docosapentaenoic acid (dpa; c22:5-n3), and docosahexaenoic acid (dha; c22:6-n3), wherein the ratio of dha to epa (dha:epa) is less than 1:20, and wherein the ratio of dha to dpa (dha:dpa) is less than 2:1 are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/10/14
20140100280
Treatment methods using very long chain polyunsaturated fatty acids
Compositions that include very long chain polyunsaturated fatty acids (vlc-pufas) are disclosed, along with methods of production and use thereof.. .
04/10/14
20140100275
Methods of administering compositions comprising docosapentaenoic acid
The present invention relates to compositions comprising docosapentaenoic acid and methods of reducing lipid parameters, such as triglycerides, total cholesterol, low density lipoprotein (ldl) cholesterol, non-hdl cholesterol, free fatty acids, and other lipids, comprising administration of omega-3 docosapentaenoic acid.. .
04/10/14
20140100274
Methods of administering compositions comprising docosapentaenoic acid
The present invention relates to compositions comprising docosapentaenoic acid and methods of reducing lipid parameters, such as triglycerides, total cholesterol, low density lipoprotein (ldl) cholesterol, non-hdl cholesterol, free fatty acids, and other lipids, comprising administration of omega-3 docosapentaenoic acid.. .
04/10/14
20140100273
Methods of administering compositions comprising docosapentaenoic acid
The present invention relates to compositions comprising docosapentaenoic acid and methods of reducing lipid parameters, such as triglycerides, total cholesterol, low density lipoprotein (ldl) cholesterol, non-hdl cholesterol, free fatty acids, and other lipids, comprising administration of omega-3 docosapentaenoic acid.. .
04/10/14
20140100272
Methods of administering compositions comprising docosapentaenoic acid
The present invention relates to compositions comprising docosapentaenoic acid and methods of reducing lipid parameters, such as triglycerides, total cholesterol, low density lipoprotein (ldl) cholesterol, non-hdl cholesterol, free fatty acids, and other lipids, comprising administration of omega-3 docosapentaenoic acid.. .
04/10/14
20140100213
Triazolones as fatty acid synthase inhibitors
This invention relates to the use of triazolone derivatives for the modulation, notably the inhibition of the activity or function of fatty acid synthase (fas). Suitably, the present invention relates to the use of triazolones in the treatment of cancer..
04/10/14
20140100191
Vesicular formulations
Disclosed herein are vesicular formulations that include one or more phospholipids and one or more surfactants and in certain embodiments the use of such formulations for the delivery of fatty acids for the treatment of disorders such as, fatty acid metabolic disorders, including essential fatty acid deficiency; pain or inflammation or osteoarthritis, more specifically for the treatment of deep tissue pain; asthma, bronchospasm, atherothrombatic cardiovascular disorders, avenous thrombatic disorders, inflammatory dermatoses disorders (e.g., atopic eczema, dishydrotic hand eczema, plaque type psoriasis, seborrheic eczema, and acne vulgaris), and dysmenorrhea.. .
04/10/14
20140100097
Urethane resin composition and a conductive roller using same
Provided is a urethane resin composition by which an electrically conductive roller which has a higher elasticity than ever and in which an air bubble in an elastic layer is fine can be obtained when the urethane resin composition is used for the elastic layer of the electrically conductive roller, and an electrically conductive roller using the same. The urethane resin composition comprises: a urethane resin having a carboxyl group on a side chain; a cross-linking agent having an epoxy group; and an ester composed of a sugar and an unbranched saturated fatty acid having 16 to 24 carbon atoms as a foaming agent.
04/10/14
20140099871
Self-contained fibrous buffing article
A self-contained fibrous buffing article including at least one layer of a fibrous nonwoven fabric; the nonwoven fabric having a hardened adherent coating including a crosslinked binder, abrasive particles, and a lubricant blend; and the lubricant blend including at least a fatty acid, mineral oil and glycerin.. .
04/10/14
20140099684
Engine worthy fatty acid methyl ester (biodiesel) from naturally occuring marine microalgal mats and marine microalgae cultured in open salt pans together with value addition of co-products
The invention teaches the obtained specifications and process of production of engine worthy marine microalgal fatty acid methyl ester (biodiesel) using naturally occurring marine microalgal mats and also marine microalgae cultivated in cost-effective manner in solar salt pans. Utility of co-product streams adds to the attractiveness of the invention..
04/10/14
20140099683
Omega-3 desaturase used in the biosynthesis of polyunsaturated fatty acids
The present invention provides novel fatty acid desaturases genes used for synthesis of polyunsaturated fatty acids, especially omega-3 desaturases (fads15). The present invention also provides nucleic acid sequence coding the above-described desaturases, expression vector of the above-described desaturases and recombinant microorganism expressing above-described desaturases..
04/10/14
20140099386
Compositions and applications of carotenoids of improved absorption and bioavailability
Micro-micelle forms of carotenoids and/or xanthophylls, which show improved absorption and biovailability by living organisms, provide higher levels of carotenoids in the blood stream, and consequently are deposited at the target tissues at a faster rate and more efficiently than crystalline carotenoids are provided. The micro-micelle forms do not contain any crystal forms of carotenoids, and are obtained as micro-micelles after melting lutein diacetate or lutein dipropionate in their natural original lipid vegetable matrix, in the presence of lipids, phospholipids, fatty acids, emulsifiers and moisture.
04/10/14
20140099385
Inhibition of fatty acid and cholesterol uptake by carbon monoxide (co)
An object of the present invention is to provide a composition for inhibiting fatty acid and cholesterol uptake in a living cell which is an inhibitor for fatty acid or cholesterol uptake by a living cell, comprising carbon monoxide (co) or a compound capable of releasing co in vivo.. .
04/10/14
20140096701
Green coalescent agent composition containing mixtures of monoesters and diesters
In particular, the invention is directed to a composition of coalescing agents comprising: (i) mixtures of (rcoo(eo)nh) monoesters and diesters; and, (ii) mixtures of (rcoo(eo)nh) monoesters and diesters obtained from the ethoxylation of fatty acids, and/or direct esterification of fatty acids with ethylene glycol derivatives, and/or transesterification, wherein the monoesters are present in an amount of 90 to 10 mass % and diesters are present in an amount of 10 to 90 mass %.. .
04/10/14
20140096577
Process of reactive trituration directly on an oil cake
A process including at least one reactive trituration step which includes putting an oil cake including from 3% to 30% oil in contact with an anhydrous light alcohol and an alkaline catalyst under temperature and time conditions that are sufficient to allow for the extraction and transesterification of the vegetable oil and lead to the production of a mixture including fatty acid esters and glycerol, and a de-oiled cake including less than 3% oil. Also, a detoxified de-oiled cake as well as to a mixture of fatty acid esters with improved stability and resistance to oxidation..
04/03/14
20140094531
Rigid polyurethane and polyisocyanurate foams based on fatty acid modified polyetherpolyols
A process for producing rigid polyurethane foams or rigid polyisocyanurate foams is provided. The process contains the reaction of polyisocyanate, fatty acid modified polyetherpolyol, polyetherpolyol, optionally flame retardant, blowing agent, catalyst, and optionally further auxiliary and/or admixture agent, wherein the polyetherpolyol is obtained by a process containing reacting orthotolylenediamine and optionally further co-starters with alkylene oxide containing ethylene oxide wherein the ethylene oxide content is more than 20 wt %, and then reacting the reaction product with alkylene oxide containing propylene oxide wherein the 1,2-propylene oxide content is more than 20 wt %, in the presence of a catalyst..
04/03/14
20140094528
Oil-based gel-like composition
Provided is a gel-forming agent that is easy to prepare and has all the properties including high safety for the living body and the environment, satisfactory gel-forming capability, comfortable feeling upon use, and good handleability. The gel-forming agent includes a lecithin, and a polyglycerol fatty acid ester in an amount of from 30 to 150 parts by weight per 100 parts by weight of the lecithin.
04/03/14
20140094526
Ph dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
Novel drug carriers capable of targeted and/or ph dependent release of biologically active agents into selected ph environments including the gastrointestinal (gi), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (ffa) are able to deliver biologically active agents to various ph environments.
04/03/14
20140094523
Solid ambroxol-containing preparation
The present invention relates to solid preparations containing ambroxol which are obtainable by melt extrusion of the mixture consisting of a) 30 to 80% by weight of ambroxol hydrochloride, b) 2 to 68% by weight of at least one hydrogenated vegetable oil, c) 2 to 68% by weight of at least one mixture containing fatty acid ester and/or hydroxy fatty acid ester and d) 0 to 66% by weight of one or more pharmaceutical adjuvants, based in each case on the total amount of the preparation and its use for secretolytic treatment in acute and chronic bronchopulmonary diseases.. .
04/03/14
20140094520
Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids, wherein at least 50% by weight of the fatty acids comprise omega-3-fatty acids, salts or derivatives thereof, wherein the omega-3 fatty acids comprise eicosapentaenoic acid (epa; c20:5-n3), docosapentaenoic acid (dpa; c22:5-n3), and docosahexaenoic acid (dha; c22:6-n3), wherein the ratio of dha to epa (dha:epa) is less than 1:20, and wherein the ratio of dha to dpa (dha:dpa) is less than 2:1 are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/03/14
20140094519
Lipoxin analogs as novel inhibitors of angiogenesis
The present invention is generally drawn to novel isolated therapeutic agents, termed lipoxins, generated from the interaction between a dietary omega-6 polyunsaturated fatty acid (pufa) such as arachidonic acid (aa), oxygenases and the analgesic aspirin (asa). Surprisingly, careful isolation of compounds generated from the combination of components in an appropriate environment provide di- and tri-hydroxy containing derivatives of aa containing compounds having unique structural and physiological properties.
04/03/14
20140094515
Cosmetic particles that transform from hard to soft particles comprising hydrogenated long-chain triglyceride oils
Cosmetic particle compositions are provided which are adapted to form hard cosmetic particles that transform to soft cosmetic particles after their incorporation into topical formulations, particularly surfactant-based topical formulations. The composition includes one or more partially or fully hydrogenated triglyceride oils, at least 50% of which have at least 15% by weight fatty acid moieties with carbon chain lengths of c18 or higher.
04/03/14
20140094439
Ph dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
Novel drug carriers capable of targeted and/or ph dependent release of biologically active agents into selected ph environments including the gastrointestinal (gi), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (ffa) are able to deliver biologically active agents to various ph environments.


Popular terms: [SEARCH]

Fatty Acid topics: Fatty Acid, Fatty Acids, Hydrocarbon, Carbon Dioxide, Internal Combustion Engine, Alkali Metal, Unsaturated Fat, Saturated Fat, Fatty Acid Amide, Carbon Atoms, Crystallize, Crystallin, Chemical Reaction, Carboxylic Acid, Electrolytic Cell

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patents related to Fatty Acid for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Fatty Acid with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.1639

3923

2 - 1 - 82